VYNE Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
Initiated Phase 2b trial of VYN201 in nonsegmental vitiligo, with top-line results expected in mid-2025Phase 1a SAD/MAD trial of VYN202...
Pharmaceutical
Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™
Applauds first FDA approval of non-injection-based epinephrine deviceReiterates expected timing for filing of New Drug Application (NDA) for Anaphylm™ (epinephrine)...
Sagimet Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
Denifanstat Phase 2b FASCINATE-2 clinical trial 52-week data was presented in June at the European Association for the Study of...
Hinge Bio, Inc. Chief Scientific Officer, Daniel Capon, Ph.D., to Present its GEM-DIMER™ Platform Technology at the University of Oxford, Kennedy Institute of Rheumatology’s Annual Translational Research Conference
Dr. Capon will present Hinge Bio’s innovative GEM-DIMER™ platform as an invited speaker at the “Pioneering Technology” Session at Trinity College,...
ProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2024
Company Anticipates Significant Sequential Growth in Quarterly Revenues Beginning in Q3 2024 and Beyond Reports Pharmaloz Growth Acceleration Has Begun...
Calibre Scientific Acquires Greyhound Chromatography, a UK Provider of Analytical Standards and Chromatography Consumables
LOS ANGELES, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of Greyhound Chromatography and...
Reviva Reports Second Quarter 2024 Financial Results and Recent Business Highlights
– Topline data from 1-year open-label extension (OLE) trial expected Q4 2024 – – Registrational RECOVER-2 trial in schizophrenia expected to...
Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results
- Reports YCANTH® revenue, net of $4.9M for second quarter of 2024 along with the expansion of YCANTH’s distribution footprint...
Evotec SE Reports H1 2024 Results: Challenging Year; Priority Reset for Sustainable Profitable Growth Gaining Momentum, Building on Core Strengths
Softness in market for Shared R&D Services, with H1 2024 revenues down 7% year-on-year. Continued growth of sales order book...
Verisante Technology, Inc. Announces Proposed RTO with SunRegen Healthcare AG
VANCOUVER, BC / ACCESSWIRE / August 13, 2024 / Verisante Technology, Inc. (TSX-V:VER.H) ("Verisante") is pleased to announce that it...
Spencer Trask & Co. Launches Dry Eye Venture Signal12 with Former Aerie Pharmaceutical Executives Thomas Mitro and Marvin Garrett
Mitro Named President & Chief Executive Officer, Readies Pro-ocular™ for Phase 3 Trials The company's breakthrough drug is the first...
LBB Specialties Expands into Puerto Rico and Latin America to Serve Growing Life Sciences Market
NORWALK, Conn., Aug. 13, 2024 /PRNewswire/ -- LBB Specialties (LBBS), a leading North American distributor of specialty chemicals and ingredients,...
CRL Announces Tru-Motion Products LLC as New Channel Partner
RED WING, Minn., Aug. 13, 2024 /PRNewswire/ -- CRL Solutions is pleased to announce the appointment of Tru-Motion Products LLC...
TEDCO’s Maryland Innovation Initiative (MII) Announces Recent Investments
$2.1M invested in seven companies to advance innovations from lab to market in Maryland COLUMBIA, Md., Aug. 13, 2024 /PRNewswire/...
Clario joins forces with Mobilise-D to advance Digital Mobility Outcomes in clinical trials
Clario integrates Mobilise-D's algorithms into Clario's Opal®️ wearable sensor system to enable real-world mobility assessments that generate accurate and reliable...
The Galien Foundation Announces 2024 Prix Galien USA Nominees for “Best Digital Health Solution,” “Best Medical Technology,” “Incubators, Accelerators and Equity,” and “Best Startup”
NEW YORK, Aug. 13, 2024 /PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences,...
LSPedia and Pharma Logistics Announce Strategic Partnership to Revolutionize Pharmaceutical Reverse Logistics and Supply Chain Visibility
FARMINGTON HILLS, Mich., Aug. 13, 2024 /PRNewswire/ -- LSPedia, a SaaS solution leader in global product traceability, proudly announces a...
Authenticx Announces AI Solution Revolutionizing Adverse Event Reporting
Latest product for detecting healthcare-specific compliance events and streamlining reporting INDIANAPOLIS, Aug. 13, 2024 /PRNewswire/ -- Authenticx, the new standard in...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Up to $16 Million Senior Secured Debt Financing from Anson Funds
This financing is expected to support 2024 filing of New Drug Applications forNRX-100 (ketamine) and NRX-101 and to support launch...
Life Sciences Community Advances Toward Next Phase of Innovation at Veeva R&D and Quality Summit
AbbVie, Astellas, Eikon, Merck, Moderna, Roche, and more share new ideas to advance drug development PLEASANTON, Calif., Aug. 13, 2024...